Who We Are Who We Serve Solutions Blog SEARCH
Contact Us
Who We AreWho We ServeSolutionsBlog
Our Leadership Our Consultants Join Our Team Latest News
340B Solutions Drug Benefit Solutions Data & Analytics
EmployersHealth PlansHospitalsLabor Unions
LibrarySpeakers BureauNews

Omnicell to Acquire Pharmaceutical Strategy Group’s 340B Link Business


August 12, 2020

Plano, Texas – Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has entered into a definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business. You’ll find all the details at omnicell.com.



PSG is the leading pharmacy intelligence and technology company solving one of healthcare’s biggest challenges – rising drug costs. We provide innovative drug management solutions to over 300 clients who rely on our team of trusted advisors to improve their financial performance.
Who We Are Who We Serve Solutions Resources Blog Join our Team Contact Privacy Policy
PHARMACEUTICAL STRATEGIES GROUP
5360 Legacy Drive | Building 3, Ste 230
Plano, TX 75024 | 800.687.4404
SERVICE DESK 844-PSG-340B